HDAC9 and colon carcinoma: Butyrate has been shown to inhibit the growth of colon carcinoma cells in several in vivo [31–32] and in vitro models [33], and this butyrate-induced cell growth inhibition and differentiation was partially due to the capacity of this SCFA to induce histone hyperacetylation via HDAC inhibition [34].